Tag
2 articles
Novo Holdings, the investment firm behind Novo Nordisk, is backing a new fund to support Italian drug startups, extending its investment reach beyond Denmark.
Breakout Ventures closes its $114 million Fund III to invest in AI-powered science startups, emphasizing the convergence of artificial intelligence and biology.